Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : XAIR save search
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
Published: 2024-03-20 (Crawled : 13:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 0.0%
H: 1.31%
C: 0.65%
air beyond million direct offering
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024
Published: 2024-02-12 (Crawled : 21:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: -12.09%
H: 0.0%
C: -6.35%
air beyond year financial
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
Published: 2024-01-18 (Crawled : 13:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: -0.36%
H: 2.88%
C: -4.68%
air conference beyond financial results
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
Published: 2023-12-27 (Crawled : 12:30) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 7.98%
H: 2.6%
C: -5.65%
beyond tumors advanced study
Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference
Published: 2023-11-15 (Crawled : 21:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 2.31%
H: 0.0%
C: -11.02%
air conference beyond
Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024
Published: 2023-11-13 (Crawled : 21:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: -26.11%
H: 6.0%
C: -6.67%
air beyond year financial results
Beyond Cancer™ Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting
Published: 2023-11-03 (Crawled : 16:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 2.03%
H: 3.98%
C: -8.76%
beyond tumors positive cancer immunotherapy meeting therapy
Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast
Published: 2023-10-19 (Crawled : 20:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 0.0%
H: 9.95%
C: 4.07%
air conference beyond financial results
Beyond Air® To Participate in the Truist Securities BioPharma Symposium
Published: 2023-10-17 (Crawled : 20:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 0.0%
H: 0.0%
C: -6.17%
air beyond symposium biopharma
Beyond Cancer™ Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice
Published: 2023-10-17 (Crawled : 12:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 0.45%
H: 11.11%
C: 8.0%
pre-clinical beyond tumor therapy
Beyond Cancer™ Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-16 (Crawled : 12:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 2.68%
H: 0.43%
C: -2.61%
conference beyond positive cancer international preclinical therapeutics therapy molecular
Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH
Published: 2023-10-16 (Crawled : 11:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 2.68%
H: 0.43%
C: -2.61%
air beyond contract technology
Beyond Cancer™ Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Published: 2023-10-04 (Crawled : 12:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 0.95%
H: 3.76%
C: 0.94%
conference beyond cancer international program therapeutics therapy molecular
Beyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities Conference
Published: 2023-10-02 (Crawled : 20:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 0.0%
H: 1.88%
C: -0.94%
air conference beyond
Beyond Cancer™ to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting
Published: 2023-09-27 (Crawled : 13:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 2.37%
H: 1.15%
C: -3.47%
beyond meeting therapy
Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder
Published: 2023-09-18 (Crawled : 20:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 0.0%
H: 9.71%
C: 6.83%
air beyond positive publication treatment preclinical
Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region
Published: 2023-09-07 (Crawled : 12:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: 0.63%
H: 3.13%
C: 0.0%
air lungfit beyond collaboration
Beyond Air® To Participate in the 2023 Cantor Global Healthcare Conference
Published: 2023-09-06 (Crawled : 11:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: -0.32%
H: 2.88%
C: 1.6%
air conference beyond global
Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024
Published: 2023-08-10 (Crawled : 20:00) - globenewswire.com
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: -3.58%
H: 11.43%
C: 3.43%
air beyond year financial
Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)
Published: 2023-08-07 (Crawled : 20:00) - globenewswire.com
JNJ | News | $145.74 0.67% -0.18% 7M
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
XAIR | $1.19 -7.03% -8.94% 220
|
Technology Services
|
| O: -0.62%
H: 16.56%
C: 14.06%
air beyond positive preclinical
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
UMAC | $1.55 0.65% 12.9% 0
|
TAOP | $1.08 13.01% 11.51% 19K
|
Technology Services
Your saved searches
Save your searches and get alerts when important news are released.